Longboard Pharmaceuticals

Longboard Pharmaceuticals : Focused on developing a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). Longboard is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies. The company is also evaluating LP659, a centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, in development for the potential treatment of multiple neurological diseases, and LP143, a centrally acting, full cannabinoid type 2 receptor (CB2) agonist, in development for the potential treatment of central nervous system (CNS) diseases and disorders.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Listing
Public, USA
Market Cap
<100MM
Website:
Address:
4275 Executive Square
Suite 950
La Jolla, CA 92037
United States

Company Participants at Solebury 1x1 Management Access Event 2023

  • Kevin Lind, President and CEO

Top 10 Holders of Longboard Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Cormorant Asset Management LP 15.59 2,118,283 9.55 13F 12/31/22
T. Rowe Price Associates, Inc. (Investment Management) 11.12 1,510,961 6.81 13F 12/31/22
HBM Partners AG (Investment Management) 9.90 1,345,009 6.07 Stakes 12/31/22
Point72 Asset Management LP 9.20 1,250,000 5.64 Stakes 2/10/23
Fidelity Management & Research Co. LLC 8.13 1,104,904 4.98 13F 12/31/22
Millennium Management LLC 7.27 987,712 4.45 13F 12/31/22
Farallon Capital Management LLC 5.97 810,500 3.66 Stakes 12/31/22
The Vanguard Group, Inc. 2.78 378,070 1.71 Funds 2/28/23
Vanguard Group, Inc. (Subfiler) 2.26 306,583 1.38 13F 12/31/22
Integral Health Asset Management LLC 1.79 243,000 1.10 13F 12/31/22

Top 10 Holders of Longboard Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Cormorant Asset Management LP 22.65 822,164 0.00 Stakes 12/31/22
Farallon Capital Management LLC 16.74 607,417 0.00 Stakes 12/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.